BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24370264)

  • 1. Statins use and risk of depression: a systematic review and meta-analysis.
    Parsaik AK; Singh B; Murad MH; Singh K; Mascarenhas SS; Williams MD; Lapid MI; Richardson JW; West CP; Rummans TA
    J Affect Disord; 2014 May; 160():62-7. PubMed ID: 24370264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and the risk of pancreatic cancer: A systematic review and meta-analysis of 2,797,186 patients.
    Karbowska E; Swieczkowski D; Gasecka A; Pruc M; Safiejko K; Ladny JR; Kopiec T; Jaguszewski MJ; Filipiak KJ; Rafique Z; Szarpak L
    Cardiol J; 2024; 31(2):243-250. PubMed ID: 35373328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.
    Lytras T; Nikolopoulos G; Bonovas S
    World J Gastroenterol; 2014 Feb; 20(7):1858-70. PubMed ID: 24587664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.
    Macedo AF; Taylor FC; Casas JP; Adler A; Prieto-Merino D; Ebrahim S
    BMC Med; 2014 Mar; 12():51. PubMed ID: 24655568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
    Kim RG; Loomba R; Prokop LJ; Singh S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1521-1530.e8. PubMed ID: 28479502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and the risk of
    Tariq R; Mukhija D; Gupta A; Singh S; Pardi DS; Khanna S
    Infect Drug Resist; 2018; 11():405-416. PubMed ID: 29559802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.
    Danaei G; Tavakkoli M; Hernán MA
    Am J Epidemiol; 2012 Feb; 175(4):250-62. PubMed ID: 22223710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies.
    Pradelli D; Soranna D; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
    Cancer Med; 2015 May; 4(5):770-80. PubMed ID: 25809667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins as an adjuvant therapy for patients with schizophrenia: An up-to-date systematic review and meta-analysis.
    Peng TR; Lin HH; Lee MC; Chen SM
    Gen Hosp Psychiatry; 2024 May; 89():75-83. PubMed ID: 38824832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review.
    Pan A; Sun Q; Okereke OI; Rexrode KM; Hu FB
    JAMA; 2011 Sep; 306(11):1241-9. PubMed ID: 21934057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoidable flaws in observational analyses: an application to statins and cancer.
    Dickerman BA; García-Albéniz X; Logan RW; Denaxas S; Hernán MA
    Nat Med; 2019 Oct; 25(10):1601-1606. PubMed ID: 31591592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological bases for repurposing statins in depression: a review of mechanistic studies.
    De Giorgi R; Rizzo Pesci N; Rosso G; Maina G; Cowen PJ; Harmer CJ
    Transl Psychiatry; 2023 Jul; 13(1):253. PubMed ID: 37438361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin Use and Liver Cancer Risk: A Meta-Epidemiological Study of Retrospective Cohort Studies by the Types of Constructed Cohort.
    Bae JM
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):777-783. PubMed ID: 38546060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and risk of depression: a Swedish national cohort study.
    Redlich C; Berk M; Williams LJ; Sundquist J; Sundquist K; Li X
    BMC Psychiatry; 2014 Dec; 14():348. PubMed ID: 25471121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype standardization for statin-induced myotoxicity.
    Alfirevic A; Neely D; Armitage J; Chinoy H; Cooper RG; Laaksonen R; Carr DF; Bloch KM; Fahy J; Hanson A; Yue QY; Wadelius M; Maitland-van Der Zee AH; Voora D; Psaty BM; Palmer CN; Pirmohamed M
    Clin Pharmacol Ther; 2014 Oct; 96(4):470-6. PubMed ID: 24897241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.
    Finegold JA; Manisty CH; Goldacre B; Barron AJ; Francis DP
    Eur J Prev Cardiol; 2014 Apr; 21(4):464-74. PubMed ID: 24623264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the risk of psychological and cognitive disorders between persistent and nonpersistent statin users.
    Lilly SM; Mortensen EM; Frei CR; Pugh MJ; Mansi IA
    Am J Cardiol; 2014 Oct; 114(7):1035-9. PubMed ID: 25212545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive decline and depressive symptoms in late-life are associated with statin use: evidence from a population-based study of Sardinian old people living in their own home.
    Mandas A; Congiu MG; Abete C; Dessi S; Manconi PE; Musio M; Columbu S; Racugno W
    Neurol Res; 2014 Mar; 36(3):247-54. PubMed ID: 24512018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of statins for the treatment of depression in patients with acute coronary syndrome.
    Kim SW; Bae KY; Kim JM; Shin IS; Hong YJ; Ahn Y; Jeong MH; Berk M; Yoon JS
    Transl Psychiatry; 2015 Aug; 5(8):e620. PubMed ID: 26285130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin Therapy and Risk of Acute Memory Impairment.
    Strom BL; Schinnar R; Karlawish J; Hennessy S; Teal V; Bilker WB
    JAMA Intern Med; 2015 Aug; 175(8):1399-405. PubMed ID: 26054031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.